Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience

Tommaso Caravita (1) , Agostina Siniscalchi (1) , Andrea Tendas (1) , Luca Cupelli (1) , Micaela Ales (1) , Alessio Perrotti (1) , Pasquale Niscola (1) , Paolo Fabritiis (1)

1 Department of Hematology S. Eugenio Hospital

Mots clés: Medicine

Tommaso Caravita, Agostina Siniscalchi, Andrea Tendas, Luca Cupelli, Micaela Ales, et al.. Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience. Annals of Hematology, 2010, 90 (1), pp.115-116. ⟨10.1007/s00277-010-0967-4⟩. ⟨hal-00554985⟩